HBV infection in hemodialysis patients: monitoring and prevention

P Carletti; L Bibiano; R Boggi; E Bordoni; A M Ricciatti; S Della Bella; P Pauri; G Salvoni; V A Mioli

doi:10.1159/000186901

HBV infection in hemodialysis patients: monitoring and prevention

Nephron. 1992;61(3):269-70. doi: 10.1159/000186901.

Authors

P Carletti¹, L Bibiano, R Boggi, E Bordoni, A M Ricciatti, S Della Bella, P Pauri, G Salvoni, V A Mioli

Affiliation

¹ Divisione di Nefrologia e Dialisi, Ospedale Regionale, Torrette, Ancona, Italy.

PMID: 1386899
DOI: 10.1159/000186901

Abstract

From 1986 to 91, 174 dialysis patients were studied. The prevalence of previous HBV infection and of chronic carriers was 33.3 and 4.6%, respectively. Immunization rate after vaccination (3 doses) was 63%. In 1991, we proposed a vaccination with 4 doses and recommend a 6-monthly anti-HBs evaluation to assess the timing of any booster dose needed.

MeSH terms

Aged
Carrier State / prevention & control
Cross Infection / prevention & control
Cross Infection / transmission
Female
Hepatitis B / prevention & control
Hepatitis B / transmission*
Hepatitis B Antibodies / blood
Hepatitis B Vaccines
Hepatitis B virus / immunology
Hepatitis, Chronic / prevention & control
Humans
Male
Middle Aged
Renal Dialysis / adverse effects*
Viral Hepatitis Vaccines / therapeutic use

Substances

Hepatitis B Antibodies
Hepatitis B Vaccines
Viral Hepatitis Vaccines